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Aim: To systematically assess the clinical performance of different approaches for 
periodontal regeneration of intrabony defects in terms of pocket resolution compared 
to access surgery with papilla preservation techniques (PPTs).
Material and Methods: Systematic literature searches were conducted on PubMed, 
EMBASE, and CENTRAL up to April 2020 to identify RCTs on regenerative treatment 
[guided tissue regeneration (GTR) or enamel matrix derivative (EMD) with or without 
biomaterials] of intrabony defects using PPTs. Results were expressed as weighted 
mean percentages (WMP) or risk ratios of pocket resolution at 12 months (considering 
both final PD ≤ 3 mm and ≤4 mm).
Results: A total of 12 RCTs were included. Based on a final PD ≤ 3 mm or PD ≤ 4 mm, 
the WMP of pocket resolution was 61.4% and 92.1%, respectively. EMD and GTR ob-
tained comparable results. Pairwise meta- analysis identified a greater probability of 
achieving pocket resolution for GTR compared to PPTs. The number needed to treat 
for GTR to obtain one extra intrabony defect achieving PD ≤ 3 mm or PD ≤ 4 mm over 
PPTs was 2 and 4, respectively.
Conclusion: Regenerative surgery represents a viable approach to obtain final 
PD ≤ 4 mm in the short- term.
K E Y W O R D S
enamel matrix derivative, guided tissue regeneration, intrabony defect, meta- analysis, 
periodontitis, pocket closure
Clinical Relevance
Scientific rationale for the study: Due to the paucity of data in literature, this systematic review 
analysed the performance of regenerative therapy in terms of percentage of pocket resolution 
(PD ≤ 3 mm or ≤4 mm).
Principal findings: The use of membrane barriers with papilla preservation techniques sig-
nificantly increased the probability of pocket resolution compared to access flap alone at 
12 months, while for the application of EMD the evidence is inconclusive.
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1  |  INTRODUC TION
Intrabony (angular) defects are the anatomical sequelae of the apical 
spread of periodontitis in which the base of the pocket is apical to 
the alveolar crest and surrounded by one, two, three residual bony 
walls or their combination (Lang & Tonetti, 2003). After the com-
pletion of initial periodontal therapy, persistent pathological pock-
ets associated with an intrabony pattern of bone resorption have 
an increased risk for disease progression and usually require further 
surgical treatment (Papapanou & Wennstrom, 1991; Papapanou & 
Tonetti, 2000; Rams et al., 2018). Many randomized controlled tri-
als and systematic reviews have shown that periodontal regenera-
tive therapies can achieve better treatment outcomes compared to 
access flap surgery in the treatment of such angular bony defects 
(Pagliaro et al., 2008; Esposito et al., 2009; Tu et al., 2010; Cortellini 
& Tonetti, 2011). While access flap surgery reduces probing depth 
(PD) by forming a long junctional epithelium attached to a previously 
diseased root surface (Caton et al., 1980), periodontal regenera-
tive procedures aim to restore the lost attachment apparatus (peri-
odontal ligament, cementum and bone) (Karring et al., 1993). To this 
regard, there is clinical and histological evidence that guided tissue 
regeneration (GTR) and enamel matrix derivatives (EMD) are the 
two most effective approaches in obtaining periodontal regenera-
tion (Cortellini et al., 1993; Sculean et al., 1999; Sanz et al., 2004; 
Needleman et al., 2006; Bosshardt, 2008).
Although the true endpoint of periodontal regeneration can be 
demonstrated only histologically, PD reduction and clinical attach-
ment level (CAL) gain are the surrogate treatment outcomes more 
commonly assessed in the clinical practice. However, changes in 
these parameters may be not clinically relevant and may not re-
flect disease remission (Chambrone & Armitage, 2016). Accordingly, 
pocket resolution has been proposed as an appropriate endpoint for 
applying the treat- to- target concept in trials evaluating the efficacy 
of active periodontal treatment (Feres et al., 2020).
Recently, Trombelli et al. (2020) proposed a composite outcome 
measure to assess the effect of regenerative treatment of intrabony 
defects in which they incorporated CAL gain and pocket resolu-
tion, defined as a post- surgery PD ≤ 4 mm. There is significant evi-
dence that residual PD > 4 mm after non- surgical and regenerative 
periodontal treatments represents a risk factor for long- term dis-
ease progression/recurrence at site level (McGuire & Nunn, 1996; 
Matuliene et al., 2008). However, considering the final goal of peri-
odontal regenerative treatment that is to restore the architecture of 
lost periodontal tissues, PD reduction on a physiological level of up 
to 3 mm would have clinical relevance for the success of periodontal 
regenerative surgery.
Despite the publication of several systematic reviews on the clin-
ical effects of regenerative therapy in the treatment of intrabony 
defects (Needleman et al., 2006; Esposito et al., 2009; Nibali et al., 
2020), a systematic assessment of the percentage of pocket resolu-
tion is still lacking. Thus, the aim of this research was to systemat-
ically review the literature on the clinical performance of GTR and 
EMD in terms of pocket resolution (considering both final PD ≤ 3 mm 
and ≤4 mm) of intrabony defects in periodontitis patients compared 
to access flap surgery with papilla preservation techniques (PPTs).
2  |  MATERIAL S AND METHODS
This systematic review was conducted according to the Cochrane 
Handbook (Higgins & Green, 2011) and reported according to the 
PRISMA statement recommendations (Moher et al., 2009). The 
PRISMA checklist is included in Table S1. The protocol was regis-
tered with PROSPERO (available from ID: CRD42020133658).
2.1  |  PICOS question
The systematic review was developed to answer the following two 
focused questions:
• “In patients with periodontitis, what is the clinical performance of 
GTR or EMD with PPTs for regeneration of intrabony defects in 
terms of pocket resolution?”
• Do regenerative procedures provide additional benefit in terms of 
pocket resolution compared to access flap surgery with PPTs?
Eligibility criteria used in this systematic review were based on 
the PICOS framework as follow (Forrest & Miller, 2002):
(P) Patient/Population: Systemically healthy adult patients af-
fected from periodontitis who at the completion of the cause- 
related periodontal therapy presented full mouth plaque score 
(FMPS) and full mouth bleeding score (FMBS) values <20% [or 
in alternative Plaque index (PI) and Gingival Index (GI) <1], and 
at least one residual periodontal intrabony defect in need of 
regenerative treatment (defect with a base apical to the inter-
dental alveolar crest, surrounded by one, two, three walls or a 
combination, PD ≥5 mm and a radiographic intrabony compo-
nent ≥3 mm).
Intervention: regenerative periodontal therapy consisting in GTR 
using resorbable or non- resorbable membranes either alone or in 
Practical implications: Pocket resolution combined with absence of BoP should be considered 
as endpoint in RCTs in order to apply the treat- to- target approach in periodontal regenerative 
treatment.
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combination with bone grafts or bone substitutes or induced tis-
sue regeneration using EMD either alone or in combination with 
bone grafts or bone substitutes. All regenerative procedures 
should employ PPTs.
C (Comparison): access flap surgery with PPTs.
O (Outcome measures): the primary outcome was the percent-
age of pocket resolution at 12 months. It was identified as the 
percentage of treated sites that converted to PD ≤3 mm or 
PD ≤ 4 mm, on the total number of treated pockets. Secondary 
outcomes were mean change in PD, mean change in CAL, patient- 
reported outcome measures (PROMs) and adverse events.
S (Type of Study): only Randomized Controlled Clinical Trials 
(RCT) in humans, with parallel or split- mouth design, were 
considered.
The following additional inclusion criteria were applied: (1) RCTs 
published in English language; (2) with a minimum follow- up time of 
12 months after surgery; (3) including at least 10 patients per arm; (4) 
reporting clinical outcomes in terms of PD changes. Exclusion crite-
ria included: (1) RCTs with unclear type of treated intrabony defects; 
(2) including teeth with furcation involvement.
2.2  |  Literature search
Electronic search was performed independently by two authors (A.F. 
and V.M.) until 30 April 2020 in the database of the National Library 
of Medicine (MEDLINE by PubMed), in the Excerpta Medica data-
BASE (EMBASE), and in the Cochrane Central Register of Controlled 
Trials (CENTRAL) using a combination of medical subject headings 
(MeSH) terms and free text words. The search strategy was first de-
signed for the MEDLINE database and was then modified for the 
other databases as reported in Table S2.
The references of all included studies and relevant reviews 
were manually crosschecked and additional search was also per-
formed in indexes of relevant dental journals (International Journal of 
Periodontics & Restorative Dentistry, Journal of Clinical Periodontology, 
Journal of Periodontal Research and Journal of Periodontology) in the 
previous 3 years.
Two independent reviewers (A.F. and V.M.) screened all arti-
cles based on titles and abstracts for adherence to the eligibil-
ity criteria. Relevant articles were analysed in full text, and any 
disagreement was resolved by discussion with a third examiner 
(M.A.). Agreement between reviewers was assessed by means 
of Cohen's K- score. When deemed necessary, the authors of the 
original studies were contacted to request further information or 
clarification. If no reply was received within 3 weeks, the study 
was excluded.
2.3  |  Data extraction and risk of bias assessment
Data of the included studies were independently extracted by two 
reviewers (A.F. and V.M.) and entered into a database. Study design, 
patient characteristics, type of intervention, clinical outcomes and 
PROMs were recorded. When the percentage of pocket resolution 
was not provided, calculations were performed based on the raw 
data reported in the paper or collected by the authors. In case of 
several articles reporting different follow- up durations on the same 
study population, 12- month data were extracted for the meta- 
analysis from the first published study.
The Cochrane Collaboration's tool (Higgins & Green, 2011) was 
used for assessing the risk of bias (low, high and unclear) of the se-
lected studies.
2.4  |  Statistical analysis
Data on treatment effect in terms of percentage of pocket resolu-
tion, PD reduction and CAL gain at 12 months were combined in 
the meta- analysis and expressed as weighted means and 95% confi-
dence intervals (CI). The risk ratios (RR) and corresponding 95% CIs 
of pocket resolution were calculated from the event rates in regen-
erative and access flap surgery groups of each of the studies and 
pooled. Studies not reporting mean differences and standard devia-
tion between baseline and 12- month examination for PD and CAL 
were excluded from the meta- analysis unless data of each patient 
were provided.
Heterogeneity was quantified using the Q test and the I2 index 
(Higgins et al., 2003). Values over 70% were classified as substantial 
heterogeneity. A random- effect model was applied when the het-
erogeneity among studies was statistically significant.
Subgroup analyses were performed on the selected outcome 
variables to explore the effect of biomaterials and type of membrane 
in tissue regenerative surgery. A forest plot was created to illustrate 
the effects of the different studies and the global estimation. The 
level of statistical significance was set at p < 0.05. Statistical anal-
yses were performed using statistical software package OpenMeta 
[Analyst].
3  |  RESULTS
3.1  |  Search results
The study selection process is presented in the flow diagram 
(Figure 1). From the initial search, 2324 records were identified, 
1202 of which were screened after duplicates removal and 72 arti-
cles were analysed in the full text. Finally, 35 met the inclusion crite-
ria. The inter- examiner agreement was excellent for the screening of 
both the abstracts and full texts (K- score = 0.87 and K- score = 0.94, 
respectively).
As data on pocket resolution were available only in 2 papers for 
PD ≤ 3 (Aimetti et al., 2017; Aslan et al., 2020), and in one paper for 
both PD ≤ 3 mm and PD ≤ 4 (Cortellini & Tonetti, 2011), the corre-
sponding authors of the included studies were contacted to request 
the row data. Lastly, 12 articles (Cortellini, Pini Prato, & Tonetti, 
4  |    AIMETTI ET Al.
1995, 1996; Cortellini et al., 2001; Christgau et al., 2002; Eickholz 
et al., 2000; Guida et al., 2007; Crea et al., 2008; Cortellini & Tonetti, 
2011; Ghezzi et al., 2016; Aimetti et al., 2017; Aslan et al., 2020; 
Paolantonio et al., 2020) were included in the final analysis. Data 
from both the experimental groups in 7 articles (Cortellini et al., 
1996; Cortellini et al., 2001; Christgau et al., 2002; Eickholz et al., 
2000; Guida et al., 2007; Crea et al., 2008; Ghezzi et al., 2016) were 
considered separately in the analysis. A list of the excluded studies 
with the reason of exclusion is available in Table S3.
3.2  |  Characteristics of the included studies
The main characteristics of selected studies are described in Table 1. All 
included studies were published between 1995 and 2020 and accounted 
for 419 patients with an age range between 21 and 70 years. Smokers 
were enrolled in 7 studies (Cortellini et al., 1995; Cortellini et al., 1996; 
Cortellini et al., 2001; Christgau et al., 2002; Guida et al., 2007; Cortellini 
& Tonetti, 2011; Ghezzi et al., 2016) for a total of 54 patients. Two of 
the included studies had a split- mouth design and were commercially 
funded (Christgau et al., 2002; Eickholz et al., 2000).
In total, 465 intrabony defects were treated. Regarding defect 
localization, Cortellini et al. (2001) selected only anterior and pre-
molar teeth, while the other studies included all types of teeth. 
Concerning defect type, Crea et al. (2008) included only three- wall 
intrabony defects, Guida et al. (2007) and Paolantonio et al. (2020) 
only one- to two- wall intrabony defects. Eickholz et al. (2000) and 
Aslan et al. (2020) selected only two- and three- wall defects.
The regenerative surgery included the application of re-
sorbable barriers (polylactide (PLA), polydioxanon (PDS) or 
F I G U R E  1  Prisma flow chart of selection process
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poly- D,L- lactide- co- glycolide) in 5 studies (Cortellini et al., 1996; 
Cortellini et al., 2001; Christgau et al., 2002; Eickholz et al., 2000; 
Ghezzi et al., 2016), non- resorbable membranes (expanded polytet-
rafluoroethylene (ePTFE) or titanium- reinforced membranes) in 
3 studies (Cortellini et al., 1995; Cortellini et al., 1996; Crea et al., 
2008), EMD alone in 4 studies (Guida et al., 2007; Crea et al., 2008; 
Cortellini & Tonetti, 2011; Aimetti et al., 2017) and in combination 
with grafting materials (bone mineral- derived xenograft or autoge-
nous cortical bone) in 5 studies (Guida et al., 2007; Cortellini & 
Tonetti, 2011; Ghezzi et al., 2016; Aslan et al., 2020; Paolantonio 
et al., 2020). Five studies and 7 datasets compared regenerative 
treatment with PPTs (Cortellini et al., 1995; Cortellini et al., 1996; 
Cortellini et al., 2001; Cortellini & Tonetti, 2011; Aslan et al., 2020).
All patients received antibiotics during the first 6– 7 days after 
treatment to prevent post- operative infection in 9 studies (Cortellini 
et al., 1995; Cortellini et al., 1996; Cortellini et al., 2001; Christgau 
et al., 2002; Guida et al., 2007; Crea et al., 2008; Ghezzi et al., 2016; 
Aslan et al., 2020; Paolantonio et al., 2020). Maintenance care was 
set on a 2– 3 month interval, except in three studies (Cortellini et al., 
1995, 1996; Aslan et al., 2020) in which professional prophylaxis was 
scheduled monthly.
3.3  |  Results from meta- analysis
3.3.1  |  Pocket resolution (PD ≤ 3 mm or PD ≤ 4 mm)
The percentage of pocket resolution considering a final PD ≤ 3 mm 
ranged from 28.6% (Guida et al., 2007) to 93.3% (Cortellini et al., 
1995) after regenerative surgery and from 11.1% (Cortellini et al., 
2001) to 80% (Aslan et al., 2020) using PPTs. Random- effects meta- 
analysis (Figure 2a) showed a weighted mean percentage (WMP) of 
pocket resolution of 61.4% (95% CI: 51.8– 71.0) after regenerative 
procedures with considerable heterogeneity (I2 = 75.21%). The ap-
plication of non- resorbable membranes (Figure 3a) obtained a WMP 
of 74.9% of pocket resolution (95% CI: 47.4– 99.6), while resorbable 
barriers achieved a WMP of 59.2% (95% CI: 47.2– 71.2). Moreover, 
the combination of EMD and grafting material (Figure 3b) yielded a 
61.5% of pocket resolution (95% CI: 42.0– 80.9), which was higher 
than EMD alone (52.7%, 95% CI: 30.2– 75.3).
As reported in Figure 4a, the use of regenerative procedures 
makes intrabony defects 1.65 times more likely to achieve a final 
PD ≤ 3 mm compared to PPTs (p = 0.040). The application of resorb-
able or non- resorbable membranes increased by 3.77- fold (95% CI: 
1.99– 7.12; p < 0.001) and 2.58- fold (95% CI: 1.51– 4.42; p < 0.001), 
respectively, the probability of pocket resolution, while the applica-
tion of EMD did not significantly improve the clinical outcome.
Considering a threshold of 4 mm (Figure 2b), 5 studies (Eickholz 
et al., 2000; Crea et al., 2008; Cortellini & Tonetti, 2011; Ghezzi 
et al., 2016; Aslan et al., 2020) with 7 data sets reported a percent-
age of pocket resolution of 100% after regenerative surgery and 
from 63.7% (Cortellini et al., 2001) to 100% (Cortellini & Tonetti, 
2011) using PPTs. Random- effects meta- analysis showed an overall 
WMP of pocket resolution after regenerative treatment of 92.1% 
(95% CI: 88.9– 95.4) with low heterogeneity (I2 = 29.52%). GTR and 
EMD (89.5% versus 94.8%), as well as non- resorbable and resorb-
able barriers (93.3% versus 88.0%), were comparably effective in ob-
taining final PD ≤4 mm (Figures 3c,d). The application of a grafting 
material did not increase the clinical performance of EMD (95.3% 
versus 92.8%). When comparing regenerative procedures with 
PPTs (Figure 4b), the use of regenerative procedures resulted in a 
1.15- fold higher probability of achieving a final PD ≤4 mm (95% CI: 
1.01– 3.31; p = 0.031); both resorbable (RR: 1.50, 95% CI: 1.19– 1.90; 
p < 0.001) and non- resorbable barriers (RR: 1.36, 95% CI: 1.05– 1.76; 
p = 0.020) performed better than PPTs with no heterogeneity among 
the studies. The number needed to treat (NNT) for GTR to obtain 
one extra intrabony defect achieving PD ≤ 3 mm or PD ≤ 4 mm over 
PPF was 2 and 4, respectively.
3.3.2  |  Mean changes in PD and CAL
As reported in Figure 5, statistical heterogeneity was detected 
as significantly high in the analysis of both PD reduction and CAL 
gain. Overall, the weighted mean PD reduction (Figure 5a) and 
weighted mean CAL gain (Figure 5b) after regenerative treatment 
were 4.56 mm (95% CI: 4.14– 4.99) and 3.89 mm (95% CI: 3.53– 4.25). 
Similar PD reduction and CAL gain were obtained when applying a 
non- resorbable membrane (5.29 mm and 4.37 mm, respectively) 
or EMD combined with a grafting material (4.73 mm and 4.37 mm, 
respectively). Resorbable membranes performed as EMD alone for 
both PD reduction (4.29 mm, versus 4.21 mm) and CAL gain (3.54 mm 
versus 3.74 mm).
Statistically significant greater PD reduction and CAL gain were 
found for regenerative procedures compared with PPTs (Figures 
5c,d) with a weighted mean difference (WMD) of 0.95 mm (95% CI: 
0.31– 1.59; p = 0.004) and 1.27 mm (95% CI: 0.28– 2.27; p = 0.012), 
respectively. The application of a resorbable membrane achieved a 
WMD of 1.43 mm for PD and 1.59 mm for CAL and the use of a 
non- resorbable barrier of 1.64 mm for PD and 2.86 mm for CAL. 
The EMD application did not provide additional benefits to the use 
of PPTs alone.
3.4  |  Adverse events
No authors reported serious adverse events. Flap dehiscence was 
observed in 7.5% of defects treated with PPTs alone (Cortellini 
et al., 2001). Infection requiring antibiotic administration occurred 
in two intrabony defects, one treated with PDS barrier (Eickholz 
et al., 2000) and the other one with PLA membrane (Crhristgau 
et al., 2002). The complication most frequently reported for GTR 
procedures was the membrane exposure with a rate of exposure 
ranging from 15% (Crea et al., 2008) to 41.7% for non- resorbable 
barriers (Cortellini et al., 1996) and from 6.5% (Christgau et al., 
2002) to 80% (Eickholz et al., 2000) for resorbable membranes 
6  |    AIMETTI ET Al.
during the first 6 post- operative weeks. The extent was always 
limited to a small portion of the interdental tissue. In the study by 
Christgau et al. (2002), the exposure of PDS membranes stead-
ily increased up to 11 mm resulting in exfoliation between 5 and 
6 weeks.
3.5  |  PROMs
Four studies (Cortellini et al., 2001; Cortellini & Tonetti, 2011; 
Aimetti et al., 2017; Aslan et al., 2020) reported data on PROMs and 
TA B L E  1  Characteristics of the included studies
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used the Visual Analogue Scale to score the degree of discomfort/
pain during the first post- operative week. Pain was absent or moder-
ate after both EMD and GTR procedures. No differences were ob-
served between regenerative procedures and PPTs in terms of pain 
intensity and duration (Cortellini et al., 2001; Cortellini & Tonetti, 
2011; Aslan et al., 2020). Pain lasted few hours after either PPT or 
PLA membrane positioning (Cortellini et al., 2001); four patients 
need pain control medication following treatment with EMD alone 
or in combination with grafting material and three patients following 
PPTs (Cortellini & Tonetti, 2011).
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First author, 
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Abbreviations: AB, autologous bone; BMDX, Bone marrow- derived xenograft; BOP, Bleeding on probing; CAL, Clinical attachment Level; CAL- V, Vertical 
attachment level; CEJ- AC, Distance from cemento- enamel Junction to alveolar crest; CEJ- BD, Distance from cemento- enamel junction to bony defect; 
CTR, control group; DBBM, Deproteinized bovine bone mineral; EMD, enamel matrix derivatives; ePTFE, Expanded polytetrafluorethylene; FMBS, Full 
Mouth Bleeding Score; FMPS, Full Mouth Plaque Score; GI, Gingival Index; INTRA, radiographic intrabony defect depth; LBS, Local bleeding score; LPS, 
Local plaque score; N.A., not available; PBI, Papillary Bleeding Index; PD, Probing depth; PDS, polydioxanon; PI, Plaque Index; PLA, polylactic- acid; PPT, 
Access flap with Papilla preservation technique; PROMs, Patient- related outcomes; RCT, Randomized clinical Trial; Rec, Gingival recession; SD, Standard 
Deviation; VBL- V, Vertical probing bone level.
Table 1 (Continued)
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Parallel RCT 10 (EMD group) a 10
5 F, 5 M
56.0 ± 8.15 PD ≥6 mm, intrabony 
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48.4 ± 9.9 PD ≥6 mm, radiographic 
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Parallel RCT (EMD group) 22 22
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N.A. PD ≥5 mm,
radiographic intrabony 
component ≥4 mm, 
predominantly 1- , 
combined 1– 2, and 2 
wall defects


















Abbreviations: AB, autologous bone; BMDX, Bone marrow- derived xenograft; BOP, Bleeding on probing; CAL, Clinical attachment Level; CAL- V, Vertical 
attachment level; CEJ- AC, Distance from cemento- enamel Junction to alveolar crest; CEJ- BD, Distance from cemento- enamel junction to bony defect; 
CTR, control group; DBBM, Deproteinized bovine bone mineral; EMD, enamel matrix derivatives; ePTFE, Expanded polytetrafluorethylene; FMBS, Full 
Mouth Bleeding Score; FMPS, Full Mouth Plaque Score; GI, Gingival Index; INTRA, radiographic intrabony defect depth; LBS, Local bleeding score; LPS, 
Local plaque score; N.A., not available; PBI, Papillary Bleeding Index; PD, Probing depth; PDS, polydioxanon; PI, Plaque Index; PLA, polylactic- acid; PPT, 
Access flap with Papilla preservation technique; PROMs, Patient- related outcomes; RCT, Randomized clinical Trial; Rec, Gingival recession; SD, Standard 
Deviation; VBL- V, Vertical probing bone level.
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10  |    AIMETTI ET Al.
3.6  |  Risk of bias assessment
The risk of bias assessment for the included RCTs is summarized in 
Figure 6. Seven papers have a low risk of bias (Aimetti et al., 2017; 
Aslan et al., 2020; Cortellini et al., 2001; Crea et al., 2008; Ghezzi 
et al., 2016; Eickholz et al., 2000; Paolantonio et al., 2020) and one 
paper (Guida et al., 2007) showed a high risk of performance bias 
due to the lack of blinding of the examiners.
4  |  DISCUSSION
The present systematic review investigated the clinical performance 
of GTR or EMD alone or in combination with grafting materials in 
terms of pocket resolution in the treatment of deep intrabony de-
fects based on existing RCTs. The obtained results from the included 
studies indicate how this endpoint of clinical success has been as-
sessed only by a few clinical studies, while most provided mean and 
standard deviation of PD and/or CAL at 12 months. This mode of 
data presentation makes it difficult for clinicians to estimate the ef-
ficacy of treatment in changing the prognosis at the tooth and site 
level (Lang & Tonetti, 2003). In view of the impossibility to have his-
tological evidence of periodontal tissue regeneration, pocket resolu-
tion remains an important parameter in clinical success estimation 
as forecaster of long- term tooth retention (Westfelt et al., 1988; 
Badersten et al., 1990; Claffey & Egelberg, 1995; Lang & Tonetti, 
2003).
It is important to establish a threshold value for pocket resolu-
tion, because cut- off points impact on the definition of successful 
therapy (Tomasi et al., 2007), and therefore, we considered two 
distinct cut- off values of ≤3 mm and ≤4 mm PD. As the goal of 
periodontal regeneration is to restore the lost periodontal attach-
ment, PD ≤3 mm represents the physiological depth of the gingi-
val sulcus. On the other hand, periodontal stability in successfully 
treated periodontitis patients has been characterized by the ab-
sence of sites with PD > 4 mm or PD = 4 mm that bleed on probing 
(Chapple et al., 2018). BoP was associated to the risk of further 
disease progression with odds ratio of 2.79 (95% CI: 1.03– 7.57) 
in a treated and well- maintained population (Armitage, 1996). 
Subjects presenting residual pockets with PD ≥4 mm and BoP 
have an incidence of tooth loss almost twice those not showing 
gingival inflammation during a supportive periodontal treatment 
(Tonetti et al., 1998). It is noteworthy that none of the included 
studies reported results in terms of composite outcome (residual 
PD and absence/presence of BoP).
In the present meta- analysis, only intrabony defects treated with 
GTR and EMD were selected based on the histological evidence of 
regeneration in humans (Cortellini et al., 1993; Sculean et al., 1999; 
Sanz et al., 2004; Needleman et al., 2006). Furthermore, previous 
systematic reviews (Murphy & Gunsolley, 2003; Graziani et al., 2012) 
highlighted the effect of the flap design on the clinical outcomes. 
Therefore, we included only studies in which PPTs were performed 
to manage interdental soft tissues.
Based on final PD ≤ 3 mm, the percentage pocket of resolution at 
12 months after regenerative treatment was largely variable across the 
studies ranging from 28.6% to 93.3%. The WMP was 61.4%, with a high 
heterogeneity probably attributable to differences in defect charac-
teristics, biomaterials applied, years of publication, learning curve and 
skill of the operators. In the subgroup analysis, the addition of a bone 
filler material to EMD increased the WMP of pocket resolution from 
52.7% to 61.5%. In parallel, a trend for non- resorbable membranes 
to perform better than resorbable barriers was observed (74.9% and 
59.2% respectively), although no direct comparison could be made. It 
should be underlined that the studies with the greatest weight in the 
meta- analysis achieved 83.3% and 93.3% probability of pocket reso-
lution (Cortellini et al., 1995, 1996). Interestingly, these studies were 
the oldest reports included and belonged to the same research group. 
Their results may have been influenced by the skill of the clinician and 
by the technique employed (e.g. non- resorbable membrane).
The overall results improved when considering 4 mm PD as 
cut- off value. The included studies reported percentages ranging 
from 71.4% to 100%. The WMP of pocket resolution increased to 
92.1% with low heterogeneity. In contrast to what we observed for 
PD ≤ 3 mm, the application of a grafting material did not increase 
the clinical performance of EMD (95.3% versus 92.8%) and the dif-
ferences between non- resorbable and resorbable membranes were 
small (93.3% versus 88.0%). It should be kept in mind that in the 
present meta- analysis, a heterogeneous group of biomaterials was 
considered and applied into predominantly two- to three- walled 
defects accessed with different PPTs techniques. The limited flap 
extension and the minimal elevation of the interdental tissue in 
more recently introduced minimally invasive procedures may have 
improved wound stability, and thus questioned the additional ben-
efit of using any supporting biomaterial for regeneration (Cortellini 
& Tonetti, 2009; Liu et al., 2016). Furthermore, the present results 
corroborate the decreasing use of non- resorbable membranes over 
the last 15 years, also in consideration of the high number of compli-
cations and the need of second surgery.
It is noteworthy that about 30% and 11.0% of deep pockets 
treated with regeneration procedures had residual PD of 4 mm and 
≥5 mm, respectively, at 12 months. Unfortunately, we did not have 
data on BoP positive sites. Considering that the treated and stable 
periodontitis patients remain at increased risk of recurrence of peri-
odontitis, it could be envisaged additional treatments.
When comparing regenerative procedures with PPTs in the 
pairwise meta- analysis, the probability of pocket resolution was 
higher for the formers for both thresholds of treatment outcomes. 
However, statistically significance was only obtained for GTR and 
not for EMD, with clinically relevant NNT values. It is relevant to 
underline how surgical techniques were not the same across the se-
lected studies, with the application of MIST in Cortellini et al. (1995, 
1996, 2001), M- MIST in Cortellini et al. (2011) and entire papilla 
preservation in Aslan et al. (2020). Among PPTs, the employment 
of a specific flap design represents a variable significantly affecting 
the final clinical results, with the raising of a single flap performing 
better than a double flap (Graziani et al., 2012).
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Cost- effectiveness data would provide essential information for 
making clinical decisions, although none of the included RCTs re-
ported it. When evaluating the few data present in the literature, 
EMD in conjunction with biomaterials was more effective than EMD 
alone, while the additional benefit of a membrane only came at rela-
tively high costs (Listl et al., 2011). It should be underlined how flap 
operation employed in that study did not comprise more modern 
minimally invasive procedures.
With regards to secondary outcomes, higher weighted mean PD 
reduction and CAL gain were achieved in intrabony defects treated 
with EMD plus biomaterials or non- resorbable membranes com-
pared to other regenerative strategies. Also, PPTs alone were less 
effective than GTR in obtaining PD reduction and CAL gain in the 
pairwise meta- analyses. These findings agree with data from previ-
ous systematic reviews (Esposito et al., 2009; Tu et al., 2010; Nibali 
et al., 2020), but it should be considered the high heterogeneity. 
F I G U R E  2  Forest plots from random effects of meta- analysis on the percentage of pocket resolution considering final PD ≤ 3 mm (a) and 
PD ≤ 4 mm (b) 12 months after regenerative surgery
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F I G U R E  3  Forest plots from random effects of meta- analysis on the percentage of pocket resolution, subgroup analysis. Final 
PD ≤ 3 mm: effect of type of membrane (a) and effect of EMD and biomaterials (b). Final PD ≤ 4 mm: effect of type of membrane (c) and 
effect of EMD and biomaterials (d)
F I G U R E  4  Forest plots from random effects of meta- analysis evaluating probability of pocket resolution (risk ratio, 95% CI) considering 
final PD ≤ 3 mm (a) and final PD ≤ 4 mm (b) after regenerative surgery compared to access flap alone with papilla preservation techniques
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Because the number of studies available for pairwise comparisons is 
few, each meta- analysis may not have sufficient power to detect any 
genuine difference between treatments.
Data on adverse events were not consistently reported and 
there was a lack of information about PROMS, thus further studies 
on these aspects should be encouraged. No serious adverse effect 
was reported, and pain/discomfort experienced by patients was 
moderate and lasting few hours.
While these data are clinically promising, the high number of 
studies excluded from the final selection represents the major lim-
itation of this study. Unfortunately, the majority of the authors 
were not able to provide raw data on pocket resolution and this 
F I G U R E  5  Forest plots from random effects of meta- analysis evaluating weighted mean changes in PD (a) and CAL (b) after regenerative 
surgery and weighted mean differences in PD reduction (c) and CAL gain (d) between regenerative surgery and access flap alone with papilla 
preservation techniques
F I G U R E  6  Risk of bias in the included studies
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may have produced loss of potentially relevant information. The 
scarcity of data did not allow for a stratified analysis depending on 
pre- operative PD, which would have yielded an adjunctive clinical 
impact to our results. In addition, by complying with our inclusion 
criteria, we included only RCTs in English language and the results 
are short- term. The evaluation period of 12 months was selected 
because it is the follow- up time used in most studies. This lim-
its the generalizability of the present conclusions. In addition, in 
some high- risk groups such as heavy smokers and subjects with 
poor plaque control the clinical benefit of periodontal regenera-
tion procedures may be limited. We did not consider smoking habit 
as exclusion criterion. Thus, smokers were enrolled in 7 studies 
and represented about 13% of the overall sample included in the 
meta- analysis, although the number of cigarettes daily smoked 
was not specified in most of them. It should be considered that in 
the last 20 years, there has been an increasing awareness of the 
dose- dependent detrimental effect of cigarette smoking on the 
outcomes of periodontal regeneration (Cortellini & Tonetti, 2015). 
Consistently, the most recent papers included in this review en-
rolled only non- smokers and light smokers (<10 cigarettes/day). 
Finally, heterogeneity across the studies was high for PD < 3 mm 
and secondary outcomes.
5  |  CONCLUSIONS
Within the limitations of the research, it can be concluded that EMD 
and GTR represent viable surgical approaches to achieve pocket 
resolution in the short- term considering final PD ≤ 4 mm. Non- 
resorbable membranes were associated with higher percentage of 
sites with final PD ≤ 3 mm at 12 months compared to PPTs. About 
30% of treated intrabony defects presented residual PD of 4 mm 
regardless of the treatment applied. However, no information on 
persistence of BoP was provided. Due the low number of the in-
cluded studies, the overall estimates from the meta- analyses should 
be interpreted with caution, despite representing best- available evi-
dence. In addition, only half of the selected studies reported a low 
risk of bias for all the methodological aspects.
This review highlights the need of more trials that use pocket 
resolution combined with absence of BoP as clinical endpoint to 
evaluate the efficacy of regenerative treatment. Authors should be 
encouraged to report longitudinal results to provide more evidence 
on the long- term benefits of periodontal regenerative therapies.
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